JUDY MURUA: Open Payments
NPI 1497461065 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 10 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $870 · 2025 $1,103
Food & beverage: $1,103
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 2 | $139 |
| Janssen Pharmaceuticals, Inc | 1 | $131 |
| Gilead Sciences, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Luye Pharma (USA) Ltd. | 1 | $121 |
| Alkermes, Inc. | 1 | $121 |
| Vanda Pharmaceuticals Inc. | 1 | $116 |
| Teva Pharmaceuticals USA, Inc. | 1 | $101 |
Products named: SUBLOCADE, INVEGA SUSTENNA, Epclusa, VRAYLAR, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE, LYBALVI, FANAPT.
Industry payments across OH — which companies pay providers there.
